(Q44700481)

English

A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 December 2017

A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis (English)

1 reference

Europe PubMed Central

5 December 2017

0 references

1 reference

based on heuristic

inferred from title

portal hypertension

1 reference

based on heuristic

inferred from title

author name string

Austin AS

1

1 reference

Europe PubMed Central

5 December 2017

Mahida YR

2

1 reference

Europe PubMed Central

5 December 2017

Clarke D

3

1 reference

Europe PubMed Central

5 December 2017

Ryder SD

4

1 reference

Europe PubMed Central

5 December 2017

Freeman JG

5

1 reference

Europe PubMed Central

5 December 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

5 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

5 December 2017

19

1 reference

Europe PubMed Central

5 December 2017

1

1 reference

Europe PubMed Central

5 December 2017

79-88

1 reference

Europe PubMed Central

5 December 2017

The treatment of portal hypertension: A meta-analytic review

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Thalidomide in the treatment of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Determination of blood volume using indocyanine green (Cardio-Green®) dye

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Carbohydrate deficient transferrin in abstaining patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Cytokine levels in acute alcoholic hepatitis: a sequential study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Rapid changes in alcoholic hepatitis histology under steroids: correlation with soluble intercellular adhesion molecule-1 in hepatic venous blood

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Combination of steroids with infliximab or placebo in severe alcoholic hepatitis: a randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Anti-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Thalidomide prevents alcoholic liver injury in rats through suppression of Kupffer cell sensitization and TNF-alpha production

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Systemic and splanchnic haemodynamic effects of pentifylline in rats with portal hypertension

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01809.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2003.01809.X

1 reference

Europe PubMed Central

5 December 2017

1 reference

Europe PubMed Central

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44700481&oldid=2032868519"